In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.
The price of AnaptysBio Inc (NASDAQ: ANAB) closed at $26.99 in the last session, down -0.04% from day before closing price of $27.0. In other words, the price has decreased by -$0.04 from its previous closing price. On the day, 0.52 million shares were traded. ANAB stock price reached its highest trading level at $28.5 during the session, while it also had its lowest trading level at $26.45.
Ratios:
We take a closer look at ANAB’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 8.25 and its Current Ratio is at 8.25. In the meantime, Its Debt-to-Equity ratio is 10.17 whereas as Long-Term Debt/Eq ratio is at 10.11.
On February 04, 2025, Wolfe Research started tracking the stock assigning a Outperform rating and target price of $25.
H.C. Wainwright Downgraded its Buy to Neutral on December 11, 2024, whereas the target price for the stock was revised from $52 to $19.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Jul 02 ’25 when RENTON HOLLINGS sold 20,925 shares for $23.57 per share. The transaction valued at 493,191 led to the insider holds 4,965 shares of the business.
HOLLINGS C RENTON bought 20,925 shares of ANAB for $493,190 on Jul 02 ’25. On Jun 18 ’25, another insider, FENTON DENNIS M, who serves as the Director of the company, sold 3,015 shares for $23.97 each. As a result, the insider received 72,270 and left with 4,965 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ANAB now has a Market Capitalization of 792979712 and an Enterprise Value of 799000576. For the stock, the TTM Price-to-Sale (P/S) ratio is 7.09 while its Price-to-Book (P/B) ratio in mrq is 24.11. Its current Enterprise Value per Revenue stands at 7.142 whereas that against EBITDA is -8.014.
Stock Price History:
The Beta on a monthly basis for ANAB is -0.18, which has changed by -0.27172154 over the last 52 weeks, in comparison to a change of 0.16564083 over the same period for the S&P500. Over the past 52 weeks, ANAB has reached a high of $41.31, while it has fallen to a 52-week low of $12.21. The 50-Day Moving Average of the stock is 15.73%, while the 200-Day Moving Average is calculated to be 29.15%.
Shares Statistics:
According to the various share statistics, ANAB traded on average about 578.89K shares per day over the past 3-months and 479150 shares per day over the past 10 days. A total of 30.39M shares are outstanding, with a floating share count of 26.44M. Insiders hold about 10.01% of the company’s shares, while institutions hold 127.83% stake in the company. Shares short for ANAB as of 1751241600 were 9362857 with a Short Ratio of 16.17, compared to 1748563200 on 9208659. Therefore, it implies a Short% of Shares Outstanding of 9362857 and a Short% of Float of 57.50999999999999.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
Earnings Estimates
The firm’s stock currently is rated by 8.0 analysts. The consensus estimate for the next quarter is -$1.57, with high estimates of -$1.23 and low estimates of -$1.86.
Analysts are recommending an EPS of between -$3.61 and -$7.02 for the fiscal current year, implying an average EPS of -$5.54. EPS for the following year is -$5.1, with 8.0 analysts recommending between -$2.64 and -$6.9.
Revenue Estimates
A total of 11 analysts have provided revenue estimates for ANAB’s current fiscal year. The highest revenue estimate was $216.9M, while the lowest revenue estimate was $27.77M, resulting in an average revenue estimate of $79.43M. In the same quarter a year ago, actual revenue was $91.28M
